In the current worldwide COVID-19 pandemic situation, fast developments are needed not only in vaccines, but also in analytical techniques to detect the infection, predict outcomes during hospitalization and more and more important towards Long COVID.
Successful development of diagnostic routines need large number of samples and spectroscopic data generated thereof as well as comprehensive metadata coverage.
Initiated by Bruker and under the guidance of the Australian National Phenome Center (ANPC) run by Prof. Jeremy Nicholson, a worldwide international COVID Research Network consisting of several institutions collaborate, using completely standardized NMR* procedures producing spectral data, exchangeable and integrable across the Network . With this webinar series, prominent members of the Network will present the advantage of exchanging data and their results along with detection, outcome prediction, and Long-COVID risks and monitoring. Take a look and register
* Bruker NMR Instruments are for research Use Only. Not for Use in Clinical Diagnostic Procedures.